Seed Health – In Collaboration with OptiBiotix – Name 2018 CPG Editor’s Choice Award Finalist
Informa Exhibitions has named Male Daily Synbiotic by Seed Health (Seed) Health Plc. as a finalist in the 2018 SupplySide CPG Editor’s Choice Awards.
Male Daily Synbiotic containg OptiBiotix’s next-generation probiotic ingredient, LPLDL®, clinically proven to lower blood pressure and cholesterol, thanks to Optibiotix’s . It was shortlisted as a finalist in the Probiotics category, along with four other brands.
Seed’s Male Daily Synbiotic combines clinically-verified, naturally-occurring, human and vegetable derived probiotic strains with a new class of patented plant-based, non-fermenting prebiotics. It is the first to take a Microbe-Systems Approach with strain-specific benefits beyond digestive health, including heart health, skin health and immune function.
Per Rehné, OptiBiotix Commercial Director, said: “We are extremely pleased to hear our revolutionary LPLDL®ingredient has helped Seed make it as a finalist for the awards. The Daily Synbiotic formulation combines expertise in microbiome modulation with consumer health and represents the potential of science-backed consumer probiotics to address a range of conditions.”
Winners will be presented with an award during the SupplySide West exhibition, November 6-10, in Las Vegas.
For 22 years, SupplySide has helped dietary supplement, food, beverage, personal care and cosmetic professionals find information to explore, discover, innovate and market their next best-selling product.
Hostedby Informa Exhibitions,SupplySide West brings together more than 15,000 ingredient buyers and suppliers from the dietary supplement, beverage, functional food, personal care and sports nutrition industries. SupplySide West is all about the science and strategy around the development of finished products that drive the global business economy. For more information visit www.supplysideshow.com.
For more information about Seed and Male Daily Synbiotic, visit seed.com/male-daily-synbiotic/.